-The Times of India Even as tuberculosis (TB) continues to haunt the world, a new study has revealed that funding for research and development of new drugs to fight the disease is floundering. Private sector funding has declined by more than a third since 2011 as pharma companies are closing their TB research programmes. Pfizer shut down its TB drug discovery programme in 2012, AstraZeneca in 2013 and Novartis in 2014. Meanwhile,...
More »SEARCH RESULT
Total Matching Records found : 50
'Paro', women sold into slavery and treated as cattle -Danish Raza
-The Hindustan Times Rubina appears much older than the 40 years she admits to. She does not look you in the eye; she is hardly audible, and often trembles. Her hut, on the outskirts of Guhana village in Haryana's Mewat district, is surrounded by garbage heaps and excreta. There is no water or electricity and the hut is filled with acrid smoke from the cooking fire. "This is how our stories...
More »Cheap medicine myth busted -GS Mudur
-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...
More »Drug price control covers too little, riddled with loopholes -GS Mudur
-The Telegraph New Delhi: The price caps imposed by the Indian government on 348 drugs earlier this year have created only an illusion of control, keeping many medicines for conditions ranging from asthma to diabetes and heart disease beyond price regulations, experts said today. The price control order issued by the department of pharmaceuticals in May has led to a 22 per cent reduction in the average cost of some 250 medicines,...
More »Activists hail report on HPV vaccines, but PATH says no violations-Aarti Dhar
-The Hindu Report points to a serious dereliction of duty by many of the institutions involved Health activists have appreciated the Parliamentary Standing Committee's report on the "Alleged Irregularities in the Conduct of Studies Using Human Papilloma Virus (HPV) Vaccine by PATH in India." They commended "its candid, transparent contents, which reflect the committee's acknowledgement of the unethical nature of the HPV trials'' conducted in the country. In the trials, Program for Appropriate...
More »
